Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
The programme is being implemented in collaboration with Grow Well Foundation and is expected to expand in a phased manner
Subscribe To Our Newsletter & Stay Updated